During the past decade, Gyeongsang National University Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 8 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 2 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gyeongsang National University Hospital" #1 sponsor was "Seoul National University Hospital" with 10 trials, followed by "Seung-Jung Park" with 7 trials sponsored, "Gyeongsang National University Hospital" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gyeongsang National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 7 trials as a collaborator, "Gyeongsang National University Hospital" with 4 trials as a collaborator, "Seoul National University Bundang Hospital" with 4 trials as a collaborator, "Asan Medical Center" with 3 trials as a collaborator and "Chonbuk National University Hospital" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Gyeongsang National University Hospital" are "Coronary Artery Disease" (12 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Breast Cancer" (3 trials), "Solid Tumor" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Gyeongsang National University Hospital" in a lesser frequency.

Most popular intervention types in "Gyeongsang National University Hospital" are "Drug" (47 trials), "Device" (9 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (7 trials), "Placebo" (5 trials), "Paclitaxel" (4 trials), "Pemetrexed" (4 trials) and "Cypher" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gyeongsang National University Hospital" are 72 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gyeongsang National University Hospital". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Gyeongsang National University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gyeongsang National University Hospital, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 5 trials that are defined as “Not Applicable".